Boston Scientific Corp. announced a restructuring plan that will incur charges of up to $800 million, involving production line transfers and job reductions. The move follows a slowdown in key product areas for the medical device manufacturer.
Boston Scientific Plans Restructuring, Up to $800 Million in Charges
BSXRestructuringMedical DevicesCorporate ActionJob Cuts



